8th European Forum for Qualified Person for Pharmacovigilance
Conference - London, United Kingdom
It is now nearly two years since the implementation of the new EU Pharmacovigilance (PV) legislation, and so it is time to reflect on the impact these changes have had on the role of the Qualified Persons for Pharmacovigilance (QPPVs) and their position and relationship with Marketing Authorisation Holders and regulatory agencies. QPPVs face multiple challenges, and the 2014 meeting will provide insights from regulators as well as MAH management into the expectations these stakeholders have of the QPPV.
Key Topics Include:
Two years later – Impact of the new EU PV requirements on the QPPV role
Risk Minimisation – Medication beliefs and behaviours, EU requirements
Metrics and KPIs – Support for QPPV oversight
Networks and Communication – Sources of information for QPPVsBeing a QPPV in Different Environments (non EU companies, contract QPPVs etc.)
Quality Systems – Compliance with GVP Module 1
PV Inspections – What’s new and what’s old (but still being found…)
Operational Challenges; e.g. the PSMF, in place and meeting Regulator needs?
Organization: DIA Europe
(Courtesy of 8th European Forum for Qualified Person for Pharmacovigilance logo, via www.gumtree.com)
8th European Forum for Qualified Person for Pharmacovigilance
Wed, May 14, 2014 - Thu, May 15, 2014
Millennium Gloucester Hotel
4-18 Harrington Gardens, London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
